The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pacific Biosciences of California Inc shares valued at $69,980 were sold by Van Oene Mark on Jan 10 ’25. At $2.03 per share, Van Oene Mark sold 34,405 shares. The insider’s holdings dropped to 1,597,454 shares worth approximately $2.89 million following the completion of this transaction.
Also, MARK VAN OENE purchased 34,405 shares, netting a total of over 69,980 in proceeds.
Before that, Kim Susan G. had sold 19,782 shares from its account. In a trade valued at $34,065, the insider traded Pacific Biosciences of California Inc shares for $1.72 each. Upon closing the transaction, the insider’s holdings decreased to 19,782 shares, worth approximately $1.26 million.
As published in a research note from UBS on November 11, 2024, Pacific Biosciences of California Inc [PACB] has been rated down from a Buy to a Neutral. As of April 22, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for PACB. Earlier on April 18, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for PACB stock which previously was a “a Buy”.
Analyzing PACB Stock Performance
During the last five days, there has been a drop of approximately -2.16%. Over the course of the year, Pacific Biosciences of California Inc shares have dropped approximately -1.09%. Shares of the company reached a 52-week high of $2.2200 on 01/08/25 and a 52-week low of $1.5900 on 01/16/25. A 50-day SMA is recorded $1.9351, while a 200-day SMA reached $1.8390. Nevertheless, trading volume fell to 10.43 million shares from 8.34 million shares the previous day.
Support And Resistance Levels for Pacific Biosciences of California Inc (PACB)
According to the 24-hour chart, there is a support level at 1.7100, which, if violated, would cause prices to drop to 1.6100. In the upper region, resistance lies at 1.8900. The next price resistance is at 1.9700. RSI (Relative Strength Index) is 46.64 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1523, which suggests the price will decrease in the coming days. Percent R is at 65.08%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
